Oxford Brain Diagnostics Seed
Founded 2019 · 13 employees on LinkedIn · 2 known investors
Oxford Brain Diagnostics develops MRI-based technology, including its Cortical Disarray Measurement (CDM) analysis, to assess brain cellular microstructure for predicting, detecting, and tracking Alzheimer's, Parkinson's, and other neurodegenerative conditions. Its tools serve clinicians and drug developers by providing imaging biomarkers for diagnosis, patient care, and clinical trials.
Investors · 2
Frequently asked questions
- What does Oxford Brain Diagnostics Seed do?
- Oxford Brain Diagnostics develops MRI-based technology, including its Cortical Disarray Measurement (CDM) analysis, to assess brain cellular microstructure for predicting, detecting, and tracking Alzheimer's, Parkinson's, and other neurodegenerative conditions. Its tools serve clinicians and drug developers by providing imaging biomarkers for diagnosis, patient care, and clinical trials.
- Who are Oxford Brain Diagnostics Seed's investors?
- Oxford Brain Diagnostics Seed's investors include Future Planet Capital, Perivoli Innovations.